CLINICAL_TRIALS
trial_result
· 2017-12-13
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme [Phase 2]
Summary
Phase 2 clinical trial of antineoplaston therapy for newly diagnosed glioblastoma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burzynski Research Institute | Conditions: Glioblastoma Multiforme of Brain | Phase 2 | Status: COMPLETED | Results posted: 2017-12-13